Cubist to Present at December Investor Conference

Oppenheimer Healthcare Conference 2012

LEXINGTON, Mass.--()--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at the Oppenheimer 23rd Annual Healthcare Conference in December 2012. Details are below.

      PRESENTER:     Steve Gilman, EVP and Chief Scientific Officer
EVENT: Oppenheimer 23rd Annual Healthcare Conference
DATE: Thursday, December 13, 2012
TIME: 10:35 a.m. Eastern Time
LOCATION: The Waldorf Astoria, New York City
WEBCAST:

Live audio with slide webcast can be accessed here.

 

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website.

Contacts

Investors:
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Senior Director, Investor Relations
eileen.mcintyre@cubist.com
or
Media:
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com

Release Summary

Cubist announces participation in Oppenheimer's 23rd Annual Healthcare on December 13, 2012.

Sharing

Contacts

Investors:
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Senior Director, Investor Relations
eileen.mcintyre@cubist.com
or
Media:
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com